
By Mariam Sunny
(Reuters) -Global measles cases fell 71% to 11 million from the year 2000 to 2024, driven by improved vaccination coverage, the World Health Organization said in a report on Friday.
Vaccination has prevented nearly 59 million deaths globally during this period, according to the report.
Deaths dropped even more sharply by 88% to 95,000 in 2024, among the lowest annual tolls since 2000.
However, estimated cases in 2024 rose 8%, while deaths dropped 11%, compared with 2019 pre-pandemic levels, reflecting a shift in disease burden from low-income to middle-income countries, which have lower fatality ratios, the report said.
Measles is often the first disease to see a resurgence when vaccination coverage drops, the agency said, adding that growing measles outbreaks expose weaknesses in immunization programmes and health systems.
Due to its high transmissibility, "even small drops in vaccine coverage can trigger outbreaks, like a fire alarm going off when smoke is detected," said Kate O'Brien, director of the Department of Immunization at WHO.
(Reporting by Mariam Sunny in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Meet the rescue team behind the astronauts as Artemis II's launch approaches - 2
Unsold Rams May Be Less expensive Than You Suspect - 3
Bowen Yang is reportedly leaving 'Saturday Night Live' after this week's episode - 4
IDF: Staying in West Bank refugee camps will quell lone-wolf terror - 5
Scientists solve the mystery of 'impossible' merger of 'forbidden' black holes
Manual for Savvy Home Lighting Framework: Lights up Your Space
Taco Bell debuts its Baja Blast pie, and the reactions may surprise you
Optimal Beauty Parlor Medicines for Upgraded Wellbeing and Appearance
Creativity Revealed: A Survey of \Making Shocking Looks\ Cosmetics Item
Wedding Guest Outraged That Bride and Groom, Who Are in Their 60s and Have Both Been Married Before, Registered for Gifts
Europe picks companies to help build Argonaut moon lander
See the first close-up photos of the moon from NASA's Artemis II mission
Creative Do-It-Yourself Ventures for Each Expertise Level
AstraZeneca to invest $2 billion as part of US manufacturing push












